Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 195 M202 M211 M225 M196 M 834 M Research & development ————— — Operating income 732 M1.51 B1.66 B1.32 B1.65 B 6.14 B Non-Operating Income, Total -499 M61 M56 M21 M-21 M 117 M Interest expense, net of interest capitalized 1.67 B1.59 B1.58 B1.56 B1.52 B 6.25 B Non-Operating Income, excl. Interest Expenses -2.17 B-1.53 B-1.52 B-1.54 B-1.54 B -6.14 B Unusual income/expense ————— — Pretax income -284 M436 M513 M386 M400 M 1.74 B Equity in earnings 26 M15 M23 M17 M17 M 72 M Taxes -59 M84 M115 M59 M81 M 339 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -225 M352 M398 M328 M319 M 1.4 B Discontinued operations ———-1 M— — Net income -225 M352 M398 M327 M319 M 1.4 B Dilution adjustment 00000 0 Preferred dividends 28 M28 M27 M27 M28 M 110 M Diluted net income available to common stockholders -253 M324 M371 M300 M291 M 1.29 B Basic earnings per share (Basic EPS) -0.821.051.190.970.94 4.15 Diluted earnings per share (Diluted EPS) -0.821.041.180.970.93 4.12 Average basic shares outstanding 309.01 M309.89 M310.34 M310.01 M310.99 M — Diluted shares outstanding 309.01 M312.43 M313.82 M313.04 M313.22 M — EBITDA 601 M1.42 B1.55 B1.21 B1.53 B 5.72 B EBIT 535 M1.36 B1.49 B1.15 B1.47 B 5.48 B Cost of revenue 161 M203 M141 M111 M121 M 576 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 66 M61 M60 M62 M59 M 242 M